HEMAFLO THERAPEUTICS
HemaFlo Therapeutics, Inc. is an early stage company founded to commercialize a novel new device for the treatment of acute kidney injury and other ischemic conditions. The device is a very dilute solution of drag-reducing polymer (DRP) that is simply delivered intravenously to patients. Drag-reducing polymers have been studied in animals since the mid-1970โs and have shown dramatic benefits in disease models such as heart attack, hemorrhagic shock, diabetes, and atherosclerosis. The work h... as received little attention because the mechanism of action was unknown until just recently. HemaFlo Therapeutics has shown that drag-reducing polymers can be used to treat a very common and deadly condition that has a very attractive commercialization pathway. Acute kidney injury has no effective treatment and there are as many new cases in the US each year as for heart attacks, strokes, and cancer combined! Acute kidney injury is not widely perceived to be a serious problem because most cases occur in the hospital as a consequence of other diseases or procedures, resolve in a week or two, and the deaths are coded as heart failure (loss of regulation of electrolytes), respiratory failure (loss of regulation of fluids), or sepsis.
HEMAFLO THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.hemaflo.com
Total Employee:
11+
Status:
Active
Contact:
(760)607-6460
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Microsoft Exchange Online Microsoft Azure DNS GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Current Employees Featured
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Grant - HemaFlo Therapeutics
More informations about "HemaFlo Therapeutics"
HemaFlo Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View HemaFlo Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
HemaFlo Therapeutics - Crunchbase Company Profile & Funding
Organization. HemaFlo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. HemaFlo Therapeutics is an early โฆSee details»
Hemaflo Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Hemaflo Therapeutics, Inc. of Carlsbad, CA. Get the latest business insights from Dun & Bradstreet.See details»
HemaFlo Therapeutics - Crunchbase
HemaFlo Therapeutics is an early stage company founded to commercialize a novel new device for the treatment of acute kidney injury.See details»
HemaFlo Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for HemaFlo Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
HemaFlo Therapeutics - Funding, Financials, Valuation & Investors
May 1, 2017 Organization. HemaFlo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding โฆSee details»
HemaFlo Therapeutics CEO, Founder, Key Executive Team, Board โฆ
Explore {HemaFlo Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
HemaFlo Therapeutics - VentureRadar
"HemaFlo is developing a drag-reducing polymer (DRP) product, HFT-012, for the treatment of acute kidney injury. Drag-reducing polymers suppress flow disturbances, flatten the flow โฆSee details»
HemaFlo Therapeutics Company Profile - Life Science Intelligence
Work for HemaFlo Therapeutics? Take ownership of your companyโs profile and submit the latest details about your company to keep the investors, strategics, and service providers using our โฆSee details»
HemaFlo Therapeutics Provides Update on Global Patent Portfolio
CARLSBAD, Calif., May 20, 2020 /PRNewswire/ -- HemaFlo Therapeutics Inc. today provided an update on its patent portfolio covering the use of drag-reducing polymers for the treatment of โฆSee details»
HemaFlo Therapeutics Provides Update on Global Patent Portfolio
CARLSBAD, Calif., May 20, 2020 /PRNewswire/ --HemaFLO Therapeutics Inc. (Formerly Known As DRP Medical) today provided an update on its patent portfolio covering the use of drag โฆSee details»
Hemab - bleeding disorder company
Leveraging validated advanced technologies and key insights into the biology of clotting, Hemabโs approach is prime for widespread expansion into a range of underserved bleeding and โฆSee details»
HEMIFLO, S.A. DE C.V.
Compra venta de medicamentos y productos hospitalarios. Dirección: Calle 27 Exterior 190 A, Interior Depto-9, García Ginerés, Mérida, Código Postal 97070,See details»
Dale Peterson - Founder and Chief Scientific Officer - Crunchbase
With a talent for forming multidisciplinary teams to commercialize challenging, valuable new medical products, Dale has successfully commercialized 18 medical devices including โฆSee details»
HemaFlo Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HemaFlo Therapeutics, Inc. of Carlsbad, CA. Get the latest business insights from Dun & Bradstreet.See details»
My Account
Access and manage your Microsoft account and organizations.See details»
HemaFlo Therapeutics, Inc. Engages VENTURE.co Brokerage โฆ
May 28, 2020 HemaFlo is a company focused on finding an effective, safe, and simple solution for Acute Kidney Injury (AKI). HemaFlo has developed and is looking to commercialize its โฆSee details»
10 Principles of Effective Organizations - Harvard Business Review
Aug 8, 2022 The author identifies 10 research-backed principles from the field of organization development to guide companies: 1) Encourage cooperation, 2) organize for change, 3) โฆSee details»
Hemoflow
These organizations have improved their blood collection efforts with HemoFlow.See details»
National member organizations: the heartbeat of the WFH
Nov 2, 2022 The World Federation of Hemophilia (WFH) was established in 1963 by Frank Schnabel, a businessman born with severe hemophilia A. His vision was to improve treatment โฆSee details»